Subtype
Pancreatic Neoplasm
CI-CAN-00001356Explore in graph →
Non-malignant987 active trials8 approved drugs63 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001356Explore in graph →
Clinical trials
4,216 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01531712 | Study of Neoadjuvant Treatment in Patients With Pancreatic Cancer That is Potentially Resectable | terminated | Phase 2 | 6 | Institut Català d'OncologiaOTHER | 1 | Aug 29, 2017 | clinicaltrials |
| NCT01515046 | Clinical Trial of High-dose Vitamin C for Advanced Pancreatic Cancer(PACMAN-II) | terminated | Phase 2 | 1 | Joseph J. CullenOTHER | 1 | Jun 8, 2017 | clinicaltrials |
| NCT00841035 | 7 Day's of Erlotinib Neo-adjuvant, Followed by Adjuvant Erlotinib-gemcitabine in Pancreatic Cancer Patients | terminated | Phase 2 | 6 | University of Alabama at BirminghamOTHER | 1 | May 19, 2017 | clinicaltrials |
| NCT02243007 | Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer | terminated | Phase 2 | 7 | Massachusetts General HospitalOTHER | 1 | May 16, 2017 | clinicaltrials |
| NCT02202785 | A Study of MLN0264 in Patients With Pancreatic Cancer | terminated | Phase 2 | 43 | Millennium Pharmaceuticals, Inc.INDUSTRY | 4 | May 15, 2017 | clinicaltrials |
| NCT00948688 | Vorinostat With XRT and 5-FU for Locally Advanced Adenocarcinoma of the Pancreas | terminated | Phase 1 / Phase 2 | 10 | Massachusetts General HospitalOTHER | 1 | May 10, 2017 | clinicaltrials |
| NCT00609765 | Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors | terminated | Phase 2 | 1 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 23, 2017 | clinicaltrials |
| NCT00907166 | A Phase I/II Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Gemcitabine in Cancer Patients | terminated | Phase 1 / Phase 2 | 6 | Cornerstone PharmaceuticalsINDUSTRY | 1 | Mar 21, 2017 | clinicaltrials |
| NCT00947167 | A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors | terminated | Phase 2 | 4 | Pamela L. KunzOTHER | 1 | Mar 3, 2017 | clinicaltrials |
| NCT01108458 | A Phase 2 Study of Pertuzumab and Erlotinib for Refractory Pancreatic Adenocarcinoma | terminated | Phase 2 | 1 | George Albert FisherOTHER | 1 | Mar 3, 2017 | clinicaltrials |
| NCT00470535 | Erlotinib in Treating Patients With Stage III or Stage IV Pancreatic Cancer | terminated | Phase 2 | 18 | Roswell Park Cancer InstituteOTHER | 1 | Feb 23, 2017 | clinicaltrials |
| NCT02242409 | Study of Gemcitabine and Abraxane for Pancreas Cancer | terminated | Phase 2 | 4 | Georgetown UniversityOTHER | 1 | Feb 14, 2017 | clinicaltrials |
| NCT02273752 | Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer | terminated | Phase 2 | 2 | Emory UniversityOTHER | 1 | Feb 3, 2017 | clinicaltrials |
| NCT01374451 | Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET(COOPERATE-2) | terminated | Phase 2 | 160 | Novartis PharmaceuticalsINDUSTRY | 19 | Dec 20, 2016 | clinicaltrials |
| NCT01050426 | A Clinical Study of UFT/Leucovorin, Radiotherapy With or Without Cetuximab Following Induction Gemcitabine Plus Capecitabine in Patients With Locally Advanced Pancreatic Cancer (PERU)(PERU) | terminated | Phase 2 | 17 | Royal Marsden NHS Foundation TrustOTHER | 1 | Oct 14, 2016 | clinicaltrials |
| NCT00726037 | A Pilot Study, Evaluating the Efficacy of Regulatory T-cell Suppression by Ontak in Metastatic Pancreatic Cancer | terminated | Phase 2 | 7 | Loyola UniversityOTHER | 1 | Sep 29, 2016 | clinicaltrials |
| NCT01188109 | Gemcitabine/Cisplatin for Resected Pancreas Cancer: Establishing the Role of ERCC1 in Treatment Decision | terminated | Phase 2 | 25 | Emory UniversityOTHER | 1 | Sep 28, 2016 | clinicaltrials |
| NCT00336700 | A Phase II Study of Gemcitabine and Erlotinib As Adjuvant Therapy In Patients With Resected Pancreatic Cancer | terminated | Phase 2 | 25 | Herbert J. Zeh, III MD, FACSOTHER | 1 | Sep 19, 2016 | clinicaltrials |
| NCT00958841 | Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin | terminated | Phase 2 | 118 | Novartis PharmaceuticalsINDUSTRY | 12 | Jul 26, 2016 | clinicaltrials |
| NCT01888965 | Maintenance Dovitinib for Colorectal and Pancreas Cancer | terminated | Phase 2 | 9 | Georgetown UniversityOTHER | 1 | Jul 19, 2016 | clinicaltrials |
| NCT00766636 | Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation Therapy | terminated | Phase 2 | 5 | M.D. Anderson Cancer CenterOTHER | 1 | May 19, 2016 | clinicaltrials |
| NCT01628913 | Efficacy and Safety of BEZ235 Compared to Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors | terminated | Phase 2 | 62 | Novartis PharmaceuticalsINDUSTRY | 8 | Apr 7, 2016 | clinicaltrials |
| NCT00198081 | Use of Celecoxib in Patients With Intraductal Papillary Mucinous Neoplasms (IPMNs) | terminated | Phase 2 | 8 | Indiana UniversityOTHER | 1 | Feb 29, 2016 | clinicaltrials |
| NCT00864513 | Study of Pemetrexed for Second-Line Pancreas Cancer | terminated | Phase 2 | 17 | Georgetown UniversityOTHER | 1 | Dec 8, 2015 | clinicaltrials |
| NCT01693276 | Gemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer | terminated | Phase 1 / Phase 2 | 3 | Olugbenga OlowokureOTHER | 1 | Oct 26, 2015 | clinicaltrials |
| NCT01042028 | A Randomised Trial With Irinotecan, Cetuximab and Everolimus (ICE)Compared to Capecitabine and Oxaliplatin (CapOx) for Patients With Gemcitabin Resistant Pancreatic Cancer | terminated | Phase 1 / Phase 2 | 39 | Per PfeifferOTHER | 1 | Oct 20, 2015 | clinicaltrials |
| NCT00544908 | Dasatinib in Treating Patients With Stage IV Pancreatic Cancer | terminated | Phase 2 | 7 | City of Hope Medical CenterOTHER | 1 | Oct 5, 2015 | clinicaltrials |
| NCT01754623 | GTX-RT in Borderline Resectable Pancreatic Cancer | terminated | Phase 2 | 9 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Aug 13, 2015 | clinicaltrials |
| NCT01080248 | Gemcitabine and Pazopanib in Metastatic Pancreatic Cancer | terminated | Phase 2 | 2 | Washington University School of MedicineOTHER | 1 | Jun 9, 2015 | clinicaltrials |
| NCT01215578 | Predictive Biomarkers of Response to Sunitinib in the Treatment of Poorly-differentiated NEURO-Endocrine Tumors(NET) | terminated | Phase 2 | 33 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Apr 30, 2015 | clinicaltrials |
| NCT01167738 | Combination Chemotherapy With or Without Metformin Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer(PACT-17) | terminated | Phase 2 | 60 | IRCCS San RaffaeleOTHER | 1 | Apr 24, 2015 | clinicaltrials |
| NCT00482625 | Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery | terminated | Phase 2 | 6 | National Cancer Institute (NCI)NIH | 1 | Oct 16, 2014 | clinicaltrials |
| NCT01227018 | PhII Study STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas Cancer | terminated | Phase 2 | 15 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jul 23, 2014 | clinicaltrials |
| NCT00003085 | Laparoscopic Ultrasound in Diagnosing Patients With Pancreatic Cancer | terminated | Phase 2 | 28 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00553813 | A Phase II Trial of TPI 287 in Patients Advanced, Unresectable Pancreatic Cancer | terminated | Phase 2 | 23 | Cortice Biosciences, Inc.INDUSTRY | 2 | Jan 22, 2014 | clinicaltrials |
| NCT00636883 | Oxaliplatin, Gemcitabine, and Erlotinib Study in Patients With Advanced Chemo-naïve Pancreatic Cancer(GEMOX-T) | terminated | Phase 2 | 9 | National Guard Health AffairsOTHER_GOV | 1 | Jan 22, 2014 | clinicaltrials |
| NCT01096732 | Hedgehog Inhibition for Pancreatic Ductal Adenocarcinoma (PDAC) in the Preoperative Setting (HIPPoS)(HIPPoS) | terminated | Phase 2 | 3 | Lisa BaxOTHER | 1 | Jan 8, 2014 | clinicaltrials |
| NCT00613730 | Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint(APPRISE 1) | terminated | Phase 2 | 3 | AmgenINDUSTRY | 0 | Jan 6, 2014 | clinicaltrials |
| NCT00587132 | Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma | terminated | Phase 1 / Phase 2 | 4 | Mayo ClinicOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00084461 | Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors | terminated | Phase 2 | 25 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00012246 | Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract | terminated | Phase 2 | 7 | The University of Texas Medical Branch, GalvestonOTHER | 1 | May 16, 2013 | clinicaltrials |
| NCT00959946 | Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 32 | PfizerINDUSTRY | 6 | Feb 22, 2013 | clinicaltrials |
| NCT00564720 | Gemcitabine Plus Erlotinib Versus Erlotinib Plus Gemcitabine Plus Oxaliplatin, in Pancreatic Cancer | terminated | Phase 2 | 140 | Hellenic Oncology Research GroupOTHER | 1 | Feb 15, 2013 | clinicaltrials |
| NCT00410774 | Gemcitabine and Bevacizumab in Treating Patients With Pancreatic Cancer That Has Been Completely Removed By Surgery | terminated | Phase 1 / Phase 2 | 20 | University of California, San FranciscoOTHER | 1 | Sep 17, 2012 | clinicaltrials |
| NCT00466856 | Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors | terminated | Phase 2 | 10 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | May 18, 2012 | clinicaltrials |
| NCT00831493 | Vorinostat Plus Radiation Therapy in Pancreatic Cancer | terminated | Phase 1 / Phase 2 | 3 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT00967291 | Mitomycin C and Ifosfamide in Treating Patients With Metastatic Pancreatic Cancer(PACT-11) | terminated | Phase 2 | 21 | IRCCS San RaffaeleOTHER | 1 | Feb 1, 2012 | clinicaltrials |
| NCT00683085 | Human Leukocyte Antigen-A*02:01-restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer | terminated | Phase 1 / Phase 2 | 2 | Tokyo UniversityOTHER | 1 | Jul 22, 2011 | clinicaltrials |
| NCT00550004 | Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine(RP101) | terminated | Phase 2 | 153 | SciClone PharmaceuticalsINDUSTRY | 13 | Jun 8, 2011 | clinicaltrials |
| NCT00326911 | Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic Cancer | terminated | Phase 2 | 61 | Eli Lilly and CompanyINDUSTRY | 1 | May 25, 2011 | clinicaltrials |
Data updated 23 days agoSource updated Aug 29, 2017source: clinicaltrials